Literature DB >> 2566070

Cardiac hypersensitivity to 5-aminosalicylic acid.

J Agnholt, H T Sørensen, S N Rasmussen, C O Gøtzsche, P Halkier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2566070     DOI： 10.1016/s0140-6736(89)92407-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Mesalazine-induced myopericarditis in a patient with ulcerative colitis.

Authors:  Levent Doganay; Baris Akinci; Nihat Pekel; Ilkay Simsek; Hale Akpinar
Journal:  Int J Colorectal Dis       Date:  2005-02-22       Impact factor: 2.571

Review 2.  Extraintestinal manifestations of inflammatory bowel disease.

Authors:  Folashade A Jose; Melvin B Heyman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-02       Impact factor: 2.839

3.  Proposed case of mesalazine-induced cardiomyopathy in severe ulcerative colitis.

Authors:  Kathryn Fleming; Andrew Ashcroft; Christopher Alexakis; Demitrios Tzias; Christopher Groves; Andrew Poullis
Journal:  World J Gastroenterol       Date:  2015-03-21       Impact factor: 5.742

Review 4.  Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.

Authors:  S B Hanauer; G Stathopoulos
Journal:  Drug Saf       Date:  1991 May-Jun       Impact factor: 5.606

Review 5.  Pleuropericarditis related to the use of mesalamine.

Authors:  N Gujral; F Friedenberg; J Friedenberg; G Gabriel; M Kotler; G Levine
Journal:  Dig Dis Sci       Date:  1996-03       Impact factor: 3.199

Review 6.  5-Aminosalicylic Acid-Associated Myocarditis and Pericarditis: A Narrative Review.

Authors:  Glen Brown
Journal:  Can J Hosp Pharm       Date:  2016-12-23

Review 7.  Comparative tolerability of therapies for ulcerative colitis.

Authors:  Sandro Ardizzone; Gabriele Bianchi Porro
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

8.  Successful Treatment with Corticosteroids in an 11-Year-Old Patient with Crohn's Disease and Myopericarditis-Case Report.

Authors:  Joanna Ryzko; Katarzyna Zdanowicz; Dariusz Marek Lebensztejn; Urszula Daniluk
Journal:  Pediatr Rep       Date:  2022-01-11

9.  Analysis of clinical characteristics of mesalazine-induced cardiotoxicity.

Authors:  Junyu Chen; Tengfei Duan; Weijin Fang; Shikun Liu; Chunjiang Wang
Journal:  Front Pharmacol       Date:  2022-09-15       Impact factor: 5.988
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.